earlier i spoke to dr richard bukola a professor at yale school of medicine in connecticut he's also the developer of another new possible vaccine for malaria i asked him how the new or in a vaccines work against the disease. the vaccine that we're working on which is still pre-clinical it's an animal testing taken just takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called pm if and by vaccinated against it the host can clear the infection on its own and we combine this vaccine an engine with a new type of r.n.a. called self amplifying arni in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject a very small amounts it can print be produced much more quickly a much lower cost $1.00 can make about a 1000000 human doses in a liter of synthetic cell free fluid so it would be potentially much easier to distr